Peak6 Investments LLC Kura Oncology, Inc. Call Options Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $971,162 - $1.27 Million	-55,400 Reduced 68.91%	25,000 $514,000
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $291,214 - $510,601	21,700 Added 36.97%	80,400 $1.71 Million
Q4 2023 Feb 13, 2024	BUY	$7.58 - $14.38 $444,946 - $844,106	58,700 New	58,700 $844,000
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $144,300 - $209,850	15,000 New	15,000 $158,000

181

80.2M

148K

63K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.31B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.